Global Biotechnology reagents Market (By Technology - life science reagents market & analytical reagents market. By Application – DNA & RNA Analysis Gene Expression, Drug Testing, Protein Synthesis & Purification, By End-User – Research Institutes, Biotech Companies, Pharmaceuticals and Diagnostic Centers); – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025
The report covers the analysis and forecast of the biotechnology reagents market on global as well as regional level. The study provides historic data of 2017 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Billion).
The study provides a detailed view of the biotechnology reagents market, by segmenting it based on, technology, application, end-user and regional demand.
The technology based segment includes two kinds namely life science reagents market and analytical reagents market. the life science reagents market can be sub-segmented into in vitro diagnostics (IVD), cell culture, polymerase chain reaction (PCR) and expression and transfection; while the analytical reagents market can be sub segmented into electrophoresis, chromatography, mass spectrometry and flow cytometry.
Based on application, the global biotechnology reagents market can be classified into DNA and RNA analysis, gene expression, drug testing and protein synthesis and purification. On the other hand, based on end-user, the market can be segmented into different research institutes, biotechnology companies, pharmaceuticals and diagnostic centers.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Market dynamics for each region has been provided in the report.
The study provides a detailed view of the biotechnology reagents market, by segmenting it based on, technology, application, end-user and regional demand.
The technology based segment includes two kinds namely life science reagents market and analytical reagents market. the life science reagents market can be sub-segmented into in vitro diagnostics (IVD), cell culture, polymerase chain reaction (PCR) and expression and transfection; while the analytical reagents market can be sub segmented into electrophoresis, chromatography, mass spectrometry and flow cytometry.
Based on application, the global biotechnology reagents market can be classified into DNA and RNA analysis, gene expression, drug testing and protein synthesis and purification. On the other hand, based on end-user, the market can be segmented into different research institutes, biotechnology companies, pharmaceuticals and diagnostic centers.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Market dynamics for each region has been provided in the report.
1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF BIOTECHNOLOGY REAGENTS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL BIOTECHNOLOGY REAGENTS MARKET SNAPSHOT
3.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET REVENUE, 2017 – 2025 (US$ BN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 TECHNOLOGY DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS, %, 2017
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 BIOTECHNOLOGY REAGENTS MARKET, BY TECHNOLOGY
5.1 OVERVIEW
5.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR LIFE SCIENCE REAGENTS MARKET, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
5.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR ANALYTICAL REAGENTS MARKET, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6 BIOTECHNOLOGY REAGENTS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR DNA & RNA ANALYSIS, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, GENE EXPRESSION VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.4 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR DRUG TESTING, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.5 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, PROTEIN SYNTHESIS & EXPRESSION VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7 BIOTECHNOLOGY REAGENTS MARKET, BY END-USER
7.1 OVERVIEW
7.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, RESEARCH INSTITUTES VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, BIOTECH COMPANIES VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.4 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, PHARMACEUTICALS VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.5 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, DIAGNOSTIC CENTERS, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
8 BIOTECHNOLOGY REAGENTS MARKET, BY GEOGRAPHY
8.1 NORTH AMERICA
8.1.1 MARKET DYNAMICS
8.1.1.1 Drivers
8.1.1.2 Restraints
8.1.1.3 Opportunity
8.1.2 U.S.
8.1.3 CANADA
8.1.4 MEXICO
8.2 EUROPE
8.2.1 MARKET DYNAMICS
8.2.1.1 Drivers
8.2.1.2 Restraints
8.2.1.3 Opportunity
8.2.2 U.K.
8.2.3 ITALY
8.2.4 FRANCE
8.2.5 GERMANY
8.2.6 RUSSIA
8.2.7 SPAIN
8.2.8 REST OF EUROPE
8.3 ASIA PACIFIC
8.3.1 MARKET DYNAMICS
8.3.1.1 Drivers
8.3.1.2 Restraints
8.3.1.3 Opportunity
8.3.2 INDIA
8.3.3 CHINA
8.3.4 JAPAN
8.3.5 AUSTRALIA
8.3.6 REST OF ASIA PACIFIC
8.4 MIDDLE EAST AND AFRICA
8.4.1 MARKET DYNAMICS
8.4.1.1 Drivers
8.4.1.2 Restraints
8.4.1.3 Opportunity
8.4.2 GCC
8.4.3 SOUTH AFRICA
8.4.4 REST OF MIDDLE EAST AND AFRICA
8.5 LATIN AMERICA
8.5.1 MARKET DYNAMICS
8.5.1.1 Drivers
8.5.1.2 Restraints
8.5.1.3 Opportunity
8.5.2 BRAZIL
8.5.3 REST OF LATIN AMERICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 NEW TECHNOLOGY LAUNCHES
10 BIOTECHNOLOGY REAGENTS MARKET, BY COMPANY
10.1 INTRODUCTION
10.2 AGILENT TECHNOLOGIES INC.
10.2.1 BUSINESS OVERVIEW
10.2.2 TECHNOLOGYS & SERVICES
10.2.3 KEY STRATEGY
10.2.4 RECENT DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 OUR COMPANY VIEW
10.3 ABBOTT LABORATORIES
10.3.1 BUSINESS OVERVIEW
10.3.2 TECHNOLOGYS & SERVICES
10.3.3 KEY STRATEGY
10.3.4 RECENT DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.3.6 OUR COMPANY VIEW
10.4 ANAVEX LIFE SCIENCES CORP.
10.4.1 BUSINESS OVERVIEW
10.4.2 TECHNOLOGYS & SERVICES
10.4.3 KEY STRATEGY
10.4.4 RECENT DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 OUR COMPANY VIEW
10.5 BECKMAN COULTER INC.
10.5.1 BUSINESS OVERVIEW
10.5.2 TECHNOLOGYS & SERVICES
10.5.3 KEY STRATEGY
10.5.4 RECENT DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 OUR COMPANY VIEW
10.6 BIO-TECHNE CORPORATION
10.6.1 BUSINESS OVERVIEW
10.6.2 TECHNOLOGYS & SERVICES
10.6.3 KEY STRATEGY
10.6.4 RECENT DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.6.6 OUR COMPANY VIEW
10.7 BECTON, DICKINSON (BD)
10.7.1 BUSINESS OVERVIEW
10.7.2 TECHNOLOGYS & SERVICES
10.7.3 KEY STRATEGY
10.7.4 RECENT DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 OUR COMPANY VIEW
10.8 BIO-RAD LABORATORIES
10.8.1 BUSINESS OVERVIEW
10.8.2 TECHNOLOGYS & SERVICES
10.8.3 KEY STRATEGY
10.8.4 RECENT DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 OUR COMPANY VIEW
10.9 BIOMERIEUX S.A
10.9.1 BUSINESS OVERVIEW
10.9.2 TECHNOLOGYS & SERVICES
10.9.3 KEY STRATEGY
10.9.4 RECENT DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 OUR COMPANY VIEW
10.10 BIOTIME INC.
10.10.1 BUSINESS OVERVIEW
10.10.2 TECHNOLOGYS & SERVICES
10.10.3 KEY STRATEGY
10.10.4 RECENT DEVELOPMENTS
10.10.5 SWOT ANALYSIS
10.10.6 OUR COMPANY VIEW
10.11 C.B.S. SCIENTIFIC COMPANY INC.
10.11.1 BUSINESS OVERVIEW
10.11.2 TECHNOLOGYS & SERVICES
10.11.3 KEY STRATEGY
10.11.4 RECENT DEVELOPMENTS
10.11.5 SWOT ANALYSIS
10.11.6 OUR COMPANY VIEW
10.12 CYANO BIOTECH GMBH
10.12.1 BUSINESS OVERVIEW
10.12.2 TECHNOLOGYS & SERVICES
10.12.3 KEY STRATEGY
10.12.4 RECENT DEVELOPMENTS
10.12.5 SWOT ANALYSIS
10.12.6 OUR COMPANY VIEW
10.13 GE HEALTHCARE
10.13.1 BUSINESS OVERVIEW
10.13.2 TECHNOLOGYS & SERVICES
10.13.3 KEY STRATEGY
10.13.4 RECENT DEVELOPMENTS
10.13.5 SWOT ANALYSIS
10.13.6 OUR COMPANY VIEW
10.14 INVIVOSCRIBE TECHNOLOGIES INC.
10.14.1 BUSINESS OVERVIEW
10.14.2 TECHNOLOGYS & SERVICES
10.14.3 KEY STRATEGY
10.14.4 RECENT DEVELOPMENTS
10.14.5 SWOT ANALYSIS
10.14.6 OUR COMPANY VIEW
10.15 LONZA GROUP LTD.
10.15.1 BUSINESS OVERVIEW
10.15.2 TECHNOLOGYS & SERVICES
10.15.3 KEY STRATEGY
10.15.4 RECENT DEVELOPMENTS
10.15.5 SWOT ANALYSIS
10.15.6 OUR COMPANY VIEW
10.16 LIFE TECHNOLOGIES CORP. (THERMO FISHER)
10.16.1 BUSINESS OVERVIEW
10.16.2 TECHNOLOGYS & SERVICES
10.16.3 KEY STRATEGY
10.16.4 RECENT DEVELOPMENTS
10.16.5 SWOT ANALYSIS
10.16.6 OUR COMPANY VIEW
10.17 MERIDIAN BIOSCIENCES, INC.
10.17.1 BUSINESS OVERVIEW
10.17.2 TECHNOLOGYS & SERVICES
10.17.3 KEY STRATEGY
10.17.4 RECENT DEVELOPMENTS
10.17.5 SWOT ANALYSIS
10.17.6 OUR COMPANY VIEW
10.18 PERKINELMER
10.18.1 BUSINESS OVERVIEW
10.18.2 TECHNOLOGYS & SERVICES
10.18.3 KEY STRATEGY
10.18.4 RECENT DEVELOPMENTS
10.18.5 SWOT ANALYSIS
10.18.6 OUR COMPANY VIEW
10.19 ROCHE
10.19.1 BUSINESS OVERVIEW
10.19.2 TECHNOLOGYS & SERVICES
10.19.3 KEY STRATEGY
10.19.4 RECENT DEVELOPMENTS
10.19.5 SWOT ANALYSIS
10.19.6 OUR COMPANY VIEW
10.20 SIGNALCHEM
10.20.1 BUSINESS OVERVIEW
10.20.2 TECHNOLOGYS & SERVICES
10.20.3 KEY STRATEGY
10.20.4 RECENT DEVELOPMENTS
10.20.5 SWOT ANALYSIS
10.20.6 OUR COMPANY VIEW
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF BIOTECHNOLOGY REAGENTS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL BIOTECHNOLOGY REAGENTS MARKET SNAPSHOT
3.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET REVENUE, 2017 – 2025 (US$ BN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 TECHNOLOGY DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS, %, 2017
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 BIOTECHNOLOGY REAGENTS MARKET, BY TECHNOLOGY
5.1 OVERVIEW
5.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR LIFE SCIENCE REAGENTS MARKET, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
5.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR ANALYTICAL REAGENTS MARKET, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6 BIOTECHNOLOGY REAGENTS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR DNA & RNA ANALYSIS, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, GENE EXPRESSION VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.4 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR DRUG TESTING, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
6.5 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, PROTEIN SYNTHESIS & EXPRESSION VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7 BIOTECHNOLOGY REAGENTS MARKET, BY END-USER
7.1 OVERVIEW
7.2 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, RESEARCH INSTITUTES VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.3 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, BIOTECH COMPANIES VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.4 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, PHARMACEUTICALS VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
7.5 GLOBAL BIOTECHNOLOGY REAGENTS MARKET FOR, DIAGNOSTIC CENTERS, VOLUME & REVENUE, 2017–2025, (UNITS) (US$ BN)
8 BIOTECHNOLOGY REAGENTS MARKET, BY GEOGRAPHY
8.1 NORTH AMERICA
8.1.1 MARKET DYNAMICS
8.1.1.1 Drivers
8.1.1.2 Restraints
8.1.1.3 Opportunity
8.1.2 U.S.
8.1.3 CANADA
8.1.4 MEXICO
8.2 EUROPE
8.2.1 MARKET DYNAMICS
8.2.1.1 Drivers
8.2.1.2 Restraints
8.2.1.3 Opportunity
8.2.2 U.K.
8.2.3 ITALY
8.2.4 FRANCE
8.2.5 GERMANY
8.2.6 RUSSIA
8.2.7 SPAIN
8.2.8 REST OF EUROPE
8.3 ASIA PACIFIC
8.3.1 MARKET DYNAMICS
8.3.1.1 Drivers
8.3.1.2 Restraints
8.3.1.3 Opportunity
8.3.2 INDIA
8.3.3 CHINA
8.3.4 JAPAN
8.3.5 AUSTRALIA
8.3.6 REST OF ASIA PACIFIC
8.4 MIDDLE EAST AND AFRICA
8.4.1 MARKET DYNAMICS
8.4.1.1 Drivers
8.4.1.2 Restraints
8.4.1.3 Opportunity
8.4.2 GCC
8.4.3 SOUTH AFRICA
8.4.4 REST OF MIDDLE EAST AND AFRICA
8.5 LATIN AMERICA
8.5.1 MARKET DYNAMICS
8.5.1.1 Drivers
8.5.1.2 Restraints
8.5.1.3 Opportunity
8.5.2 BRAZIL
8.5.3 REST OF LATIN AMERICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 NEW TECHNOLOGY LAUNCHES
10 BIOTECHNOLOGY REAGENTS MARKET, BY COMPANY
10.1 INTRODUCTION
10.2 AGILENT TECHNOLOGIES INC.
10.2.1 BUSINESS OVERVIEW
10.2.2 TECHNOLOGYS & SERVICES
10.2.3 KEY STRATEGY
10.2.4 RECENT DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 OUR COMPANY VIEW
10.3 ABBOTT LABORATORIES
10.3.1 BUSINESS OVERVIEW
10.3.2 TECHNOLOGYS & SERVICES
10.3.3 KEY STRATEGY
10.3.4 RECENT DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.3.6 OUR COMPANY VIEW
10.4 ANAVEX LIFE SCIENCES CORP.
10.4.1 BUSINESS OVERVIEW
10.4.2 TECHNOLOGYS & SERVICES
10.4.3 KEY STRATEGY
10.4.4 RECENT DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 OUR COMPANY VIEW
10.5 BECKMAN COULTER INC.
10.5.1 BUSINESS OVERVIEW
10.5.2 TECHNOLOGYS & SERVICES
10.5.3 KEY STRATEGY
10.5.4 RECENT DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 OUR COMPANY VIEW
10.6 BIO-TECHNE CORPORATION
10.6.1 BUSINESS OVERVIEW
10.6.2 TECHNOLOGYS & SERVICES
10.6.3 KEY STRATEGY
10.6.4 RECENT DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.6.6 OUR COMPANY VIEW
10.7 BECTON, DICKINSON (BD)
10.7.1 BUSINESS OVERVIEW
10.7.2 TECHNOLOGYS & SERVICES
10.7.3 KEY STRATEGY
10.7.4 RECENT DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 OUR COMPANY VIEW
10.8 BIO-RAD LABORATORIES
10.8.1 BUSINESS OVERVIEW
10.8.2 TECHNOLOGYS & SERVICES
10.8.3 KEY STRATEGY
10.8.4 RECENT DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 OUR COMPANY VIEW
10.9 BIOMERIEUX S.A
10.9.1 BUSINESS OVERVIEW
10.9.2 TECHNOLOGYS & SERVICES
10.9.3 KEY STRATEGY
10.9.4 RECENT DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 OUR COMPANY VIEW
10.10 BIOTIME INC.
10.10.1 BUSINESS OVERVIEW
10.10.2 TECHNOLOGYS & SERVICES
10.10.3 KEY STRATEGY
10.10.4 RECENT DEVELOPMENTS
10.10.5 SWOT ANALYSIS
10.10.6 OUR COMPANY VIEW
10.11 C.B.S. SCIENTIFIC COMPANY INC.
10.11.1 BUSINESS OVERVIEW
10.11.2 TECHNOLOGYS & SERVICES
10.11.3 KEY STRATEGY
10.11.4 RECENT DEVELOPMENTS
10.11.5 SWOT ANALYSIS
10.11.6 OUR COMPANY VIEW
10.12 CYANO BIOTECH GMBH
10.12.1 BUSINESS OVERVIEW
10.12.2 TECHNOLOGYS & SERVICES
10.12.3 KEY STRATEGY
10.12.4 RECENT DEVELOPMENTS
10.12.5 SWOT ANALYSIS
10.12.6 OUR COMPANY VIEW
10.13 GE HEALTHCARE
10.13.1 BUSINESS OVERVIEW
10.13.2 TECHNOLOGYS & SERVICES
10.13.3 KEY STRATEGY
10.13.4 RECENT DEVELOPMENTS
10.13.5 SWOT ANALYSIS
10.13.6 OUR COMPANY VIEW
10.14 INVIVOSCRIBE TECHNOLOGIES INC.
10.14.1 BUSINESS OVERVIEW
10.14.2 TECHNOLOGYS & SERVICES
10.14.3 KEY STRATEGY
10.14.4 RECENT DEVELOPMENTS
10.14.5 SWOT ANALYSIS
10.14.6 OUR COMPANY VIEW
10.15 LONZA GROUP LTD.
10.15.1 BUSINESS OVERVIEW
10.15.2 TECHNOLOGYS & SERVICES
10.15.3 KEY STRATEGY
10.15.4 RECENT DEVELOPMENTS
10.15.5 SWOT ANALYSIS
10.15.6 OUR COMPANY VIEW
10.16 LIFE TECHNOLOGIES CORP. (THERMO FISHER)
10.16.1 BUSINESS OVERVIEW
10.16.2 TECHNOLOGYS & SERVICES
10.16.3 KEY STRATEGY
10.16.4 RECENT DEVELOPMENTS
10.16.5 SWOT ANALYSIS
10.16.6 OUR COMPANY VIEW
10.17 MERIDIAN BIOSCIENCES, INC.
10.17.1 BUSINESS OVERVIEW
10.17.2 TECHNOLOGYS & SERVICES
10.17.3 KEY STRATEGY
10.17.4 RECENT DEVELOPMENTS
10.17.5 SWOT ANALYSIS
10.17.6 OUR COMPANY VIEW
10.18 PERKINELMER
10.18.1 BUSINESS OVERVIEW
10.18.2 TECHNOLOGYS & SERVICES
10.18.3 KEY STRATEGY
10.18.4 RECENT DEVELOPMENTS
10.18.5 SWOT ANALYSIS
10.18.6 OUR COMPANY VIEW
10.19 ROCHE
10.19.1 BUSINESS OVERVIEW
10.19.2 TECHNOLOGYS & SERVICES
10.19.3 KEY STRATEGY
10.19.4 RECENT DEVELOPMENTS
10.19.5 SWOT ANALYSIS
10.19.6 OUR COMPANY VIEW
10.20 SIGNALCHEM
10.20.1 BUSINESS OVERVIEW
10.20.2 TECHNOLOGYS & SERVICES
10.20.3 KEY STRATEGY
10.20.4 RECENT DEVELOPMENTS
10.20.5 SWOT ANALYSIS
10.20.6 OUR COMPANY VIEW
